Zydus Lifesciences got USFDA approval for Celecoxib capsules (50–400 mg) to treat arthritis, JIA, and AS. Made in Ahmedabad, ...

Inflammatory back pain (IBP), typically perceived in the sacroiliac region, is often the earliest harbinger for the development of axial spondyloarthropathy (SpA), including ankylosing spondylitis (AS ...

Ankylosing spondylitis causes chronic back pain and joint fusion, affecting millions. Learn the early warning signs and what triggers this disease.

Objectives Anatomical variation of the sacroiliac (SI) joints is common and specific variants are associated with erosions and bone marrow oedema on imaging. Our investigation aims to evaluate whether ...

Patients with ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) exhibit distinct clinical and radiographic features when compared against those without IBD, including lower HLA-B27 ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints ...

Axial spondyloarthritis manifests as a chronic inflammatory disease primarily affecting the sacroiliac joints and spine. Although chronic back pain and spinal stiffness are typical initial symptoms, ...

A diagnostic delay of 2 to 6 years may be typical in axSpA, noted Raj Sengupta, MBBS, of the University of Bath in England, and co-authors in a recent review. "This time span presents a window of ...

There were no differences in disease activity, mobility, radiographic damage in the spine (Modified Stoke Ankylosing Spondylitis Spine Score– mSASSS), or sacroiliac magnetic resonance imaging (MRI) ...

Active disease according to standard clinical evaluations (e.g., Bath Ankylosing Spondylitis Disease Activity Index score ≥4) was required for eligibility in the original trials.